ATS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Kit V. Arom
Robert W. Emery
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Arom, K. V.
Right arrow Articles by Emery, R. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Arom, K. V.
Right arrow Articles by Emery, R. W.

Ann Thorac Surg 1994;57:1108-1113
© 1994 The Society of Thoracic Surgeons

Articles

Decreased postoperative drainage with addition of {epsilon}-aminocaproic acid before cardiopulmonary bypass

Kit V. Arom, MD, PhD*, Robert W. Emery, MD

Minneapolis Heart Institute, Minneapolis, Minnesota, USA

* Address reprint requests to Dr Arom, 920 E 28th St, Suite 420, Minneapolis, MN 55407.

Desmopressin (DDAVP, 0.3 µg/kg) has been used routinely after cardiopulmonary bypass, particularly in patients having antiplatelet therapy Recently {epsilon}-aminocaproic acid (single dose of 5 g) given before cardiopulmonary bypass has been added to the protocol. One hundred consecutive patients taking desmopressin and {epsilon}-aminocaproic acid (group A) and another 100 taking desmo pressin alone (group B) were analyzed. There was no difference among these two groups in patient age, sex, preoperative history of bleeding and drug consumption, or number of patients for elective, urgent, emergent, redo, and reoperation for bleeding. Results of routine preoperative coagulation studies were within normal limits in both groups. Preoperative hemoglobin level was 13.5 g/dL in group A and 13.8 g/dL in group B (p = 0.12). Estimated blood loss in the operating room was 513 mL for group A and 587 mL for group B (p = 0.07). The total chest drainage at the end of 24 hours was 492 mL in group A and 746 mL in group B (p = 0.0001). Amicar given before cardiopulmonary bypass does not lessen operating room blood loss, but significantly decreases postoperative chest drainage. Group B patients received more fresh frozen plasma (60 U versus 4 U), more platelets (130 U versus 16 U), and more cryoprecipitate (118 U versus 10 U) than group A patients. Adding {epsilon}-aminocaproic add could save $206.18 in blood product use per patient compared with the expense of $24.12 per patient for E-aminocaproic acid administration.




This article has been cited by other articles:


Home page
 Arch SurgHome page
J. M. O'Riordan, R. J. Margey, G. Blake, and P. R. O'Connell
Antiplatelet Agents in the Perioperative Period
Arch Surg, January 1, 2009; 144(1): 69 - 76.
[Abstract] [Full Text] [PDF]

Home page
 Card Surg AdultHome page
L. Y. Lee, W. J. DeBois, K. H. Krieger, and O. W. Isom
Transfusion Therapy and Blood Conservation
Card. Surg. Adult, January 1, 2008; 3(2008): 415 - 430.
[Full Text]

Home page
 Card Surg AdultHome page
L. Y. Lee, W. J. DeBois, K. H. Krieger, and O. W. Isom
Transfusion Therapy and Blood Conservation
Card. Surg. Adult, January 1, 2003; 2(2003): 389 - 400.
[Full Text]

Home page
 Card Surg AdultHome page
R. Salenger, J. S. Gammie, and T. J. Vander Salm
Postoperative Care of Cardiac Surgical Patients
Card. Surg. Adult, January 1, 2003; 2(2003): 439 - 469.
[Full Text]

Home page
 Card Surg AdultHome page
Y. J. Woo and T. J. Gardner
Myocardial Revascularization with Cardiopulmonary Bypass
Card. Surg. Adult, January 1, 2003; 2(2003): 581 - 607.
[Full Text]

Home page
 J. Thorac. Cardiovasc. Surg.Home page
E. Ozal, E. Kuralay, H. Bingol, F. Cingoz, S. Ceylan, and H. Tatar
Does tranexamic acid reduce desmopressin-induced hyperfibrinolysis?
J. Thorac. Cardiovasc. Surg., March 1, 2002; 123(3): 539 - 543.
[Abstract] [Full Text] [PDF]

Home page
 Anesth. Analg.Home page
M. Stafford-Smith, B. Phillips-Bute, D. N. Reddan, J. Black, and M. F. Newman
The Association of {epsilon}-Aminocaproic Acid with Postoperative Decrease in Creatinine Clearance in 1502 Coronary Bypass Patients
Anesth. Analg., October 1, 2000; 91(5): 1085 - 1090.
[Abstract] [Full Text] [PDF]

Home page
 Anesth. Analg.Home page
R. Saleem, M. Bigham, E. Spitznagel, and G. J. Despotis
The Effect of Epsilon-Aminocaproic Acid on HemoSTATUS(R) and Kaolin-Activated Clotting Time Measurements
Anesth. Analg., June 1, 2000; 90(6): 1281 - 1285.
[Abstract] [Full Text] [PDF]

Home page
 Asian Cardiovasc. Thorac. Ann.Home page
S. Chauhan, A. K. Bisoi, B. H. Rao, M S. Rao, N. Saxena, P. Venugopal, S. Chauhan, A. K. Bisoi, B. H. Rao, M S. Rao, et al.
Dosage of Epsilon-Aminocaproic Acid to Reduce Postoperative Blood Loss
Asian Cardiovasc Thorac Ann, March 1, 2000; 8(1): 15 - 18.
[Abstract] [Full Text] [PDF]

Home page
 Ann. Thorac. Surg.Home page
M. P. Pelletier, S. Solymoss, A. Lee, and R. C.-J. Chiu
Negative Reexploration for Cardiac Postoperative Bleeding: Can It Be Therapeutic?
Ann. Thorac. Surg., April 1, 1998; 65(4): 999 - 1002.
[Abstract] [Full Text] [PDF]

Home page
 Ann. Thorac. Surg.Home page
J.-F. Hardy, S. Belisle, C. Dupont, F. Harel, D. Robitaille, M. Roy, and L. Gagnon
Prophylactic Tranexamic Acid and {epsilon}-Aminocaproic Acid for Primary Myocardial Revascularization
Ann. Thorac. Surg., February 1, 1998; 65(2): 371 - 376.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
P. M. Mannucci
Desmopressin (DDAVP) in the Treatment of Bleeding Disorders: The First 20 Years
Blood, October 1, 1997; 90(7): 2515 - 2521.
[Full Text] [PDF]

Home page
 J. Thorac. Cardiovasc. Surg.Home page
S. Cicek, U. Demirkilic, E. Ozal, E. Kuralay, H. Bingol, H. Tatar, and O. Y. Ozturk
POSTOPERATIVE USE OF APROTININ IN CARDIAC OPERATIONS: AN ALTERNATIVE TO ITS PROPHYLACTIC USE
J. Thorac. Cardiovasc. Surg., December 1, 1996; 112(6): 1462 - 1467.
[Abstract] [Full Text]

Home page
 J. Thorac. Cardiovasc. Surg.Home page
M. N. D'Ambra, C. W. Akins, E. H. Blackstone, S. L. Bonney, L. H. Cohn, D. M. Cosgrove, J. H. Levy, K. E. Lynch, and R. Maddi
APROTININ IN PRIMARY VALVE REPLACEMENT AND RECONSTRUCTION: A MULTICENTER, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL
J. Thorac. Cardiovasc. Surg., October 1, 1996; 112(4): 1081 - 1089.
[Abstract] [Full Text]

Home page
 J. Thorac. Cardiovasc. Surg.Home page
T. J. Vander Salm, S. Kaur, R. A. Lancey, O. N. Okike, A. T. Pezzella, R. F. Stahl, L. Leone, J.-M. Li, C. R. Valeri, and A. D. Michelson
REDUCTION OF BLEEDING AFTER HEART OPERATIONS THROUGH THE PROPHYLACTIC USE OF EPSILON-AMINOCAPROIC ACID
J. Thorac. Cardiovasc. Surg., October 1, 1996; 112(4): 1098 - 1107.
[Abstract] [Full Text]

Home page
 Ann. Thorac. Surg.Home page
S. Cicek, U. Demirkilic, E. Kuralay, E. Ozal, and H. Tatar
Postoperative Aprotinin: Effect on Blood Loss and Transfusion Requirements in Cardiac Operations
Ann. Thorac. Surg., May 1, 1996; 61(5): 1372 - 1376.
[Abstract] [Full Text]

Home page
 PerfusionHome page
R. M Montesano, P. A Gustafson, D. A Palanzo, N. J Manley, and F. S Sadr
The effect of low-dose epsilon-aminocaproic acid on patients following coronary artery bypass surgery
Perfusion, January 1, 1996; 11(1): 53 - 56.
[Abstract] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 1994 by The Society of Thoracic Surgeons.